# A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.

> **NCT01551797** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Paracetamol 500 mg
- **DRUG:** Paracetamol 1000 mg
- **DRUG:** Paracetamol 750 mg

## Key facts

- **NCT ID:** NCT01551797
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551797, "A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01551797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*